[18F]-3′Deoxy-3′-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel

201189 citationsJournal Article

Authors

Kaiyumars Contractor · Imperial College Healthcare NHS Trust

Laura Kenny · Charing Cross Hospital

Justin Stebbing · Imperial College Healthcare NHS Trust

Lula Rosso · Imperial College Healthcare NHS Trust

Rizvana Ahmad · Imperial College Healthcare NHS Trust

Jimmy Jacob · Imperial College London

Amarnath Challapalli

Abstract

Changes in tumor proliferation assessed by FLT-PET early after initiating docetaxel chemotherapy can predict lesion response midtherapy with good sensitivity warranting prospective trials to assess the ability to stop therapy in the event of non-FLT-PET response.

Topics & Keywords

Cancer Treatment and Pharmacology Medical Imaging Techniques and Applications Glioma Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Cancer Research

Volume 17, Issue 24, pp. 7664-7672

DOI: 10.1158/1078-0432.ccr-11-0783

Field-Weighted Citation Impact: 5.06